A, P., I, G., E, B., M, D., A, P., A, P., . . . M, B. (2025). Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs. Medicina (Kaunas, Lithuania), 61(1), . https://doi.org/10.3390/medicina61010102
Chicago Style (17th ed.) CitationA, Pau, Galliano I, Barnini E, Dini M, Pizzol A, Ponte A, Gambarino S, Calvo PL, and Bergallo M. "Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs." Medicina (Kaunas, Lithuania) 61, no. 1 (2025). https://doi.org/10.3390/medicina61010102.
MLA (9th ed.) CitationA, Pau, et al. "Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs." Medicina (Kaunas, Lithuania), vol. 61, no. 1, 2025, https://doi.org/10.3390/medicina61010102.